Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Active Biotech ACTI Jul 20, 2018 6.24 -9.43   
 AddLife AB ALIFB Jul 20, 2018 203.00 -0.49   
 Arjo B ARJOB Jul 20, 2018 30.00 +3.45   
 AstraZeneca AZN Jul 20, 2018 659.20 -0.27   
 Attendo AB ATT Jul 20, 2018 76.95 -0.58   
 Bactiguard Holding AB BACTIB Jul 20, 2018 37.00 -2.12   
 BBS-Bioactive Bone Substitutes BONES Jul 20, 2018 40.00 0.00   
 Biogaia B BIOGB Jul 20, 2018 407.50 -0.37   
 Bioinvent BINV Jul 20, 2018 2.29 +1.32   
 Biotage BIOT Jul 20, 2018 109.20 -0.18   
 Boule Diagnostics BOUL Jul 20, 2018 75.50 +0.67   
 Camurus AB CAMX Jul 20, 2018 94.80 +0.42   
 Capio AB CAPIO Jul 20, 2018 52.70 +0.38   
 Elekta B EKTAB Jul 20, 2018 124.00 +1.60   
 Feelgood FEEL Jul 20, 2018 3.58 -2.59   
 Follicum AB FOLLI Jul 20, 2018 2.66 -1.12   
 Getinge B GETIB Jul 20, 2018 92.28 +0.85   
 GHP Specialty Care AB GHP Jul 20, 2018 11.80 +0.85   
 Humana AB HUM Jul 20, 2018 61.30 -0.81   
 Karo Pharma AB KARO Jul 20, 2018 32.85 +2.50   
 MedCap AB MCAP Jul 20, 2018 92.60 +1.76   
 Medivir B MVIRB Jul 20, 2018 33.55 +1.98   
 Moberg Pharma AB MOB Jul 20, 2018 38.15 +1.46   
 NeuroVive Pharmaceutic.. NVP Jul 20, 2018 5.11 -0.78   
 Oasmia Pharmaceutical OASM Jul 20, 2018 4.76 -3.25   
 Orexo ORX Jul 20, 2018 41.30 +2.23   
 Ortivus A ORTIA Jul 20, 2018 4.00 -7.61   
 Ortivus B ORTIB Jul 20, 2018 1.93 +4.67   
 PExA AB PEXAB Jul 20, 2018 2.80 0.00   
 Probi PROB Jul 20, 2018 363.80 -4.21   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK